Hyperion Imaging System
The Hyperion™ Imaging System brings together imaging capability with proven CyTOF® technology to facilitate Imaging Mass Cytometry™ applications. This allows highly multiplexed immunohistochemistry enabling the simultaneous analysis of 4 to 37 protein markers. Deep interrogation of tissues or tumors at subcellular resolution can empower the identification of new prognostic and diagnostic biomarkers and provide key insights into disease progression, response to therapy or drug mechanisms in the future.
Discover more about Imaging Mass Cytometry.
Improving care is a mission that drives us all. Translating new discoveries into better clinical outcomes takes dedication and new approaches to asking the most difficult questions. At Fluidigm, we believe that changing the course of how diseases are treated and ultimately cured requires a comprehensive understanding of complex cellular phenotypes and their interrelationships within the tissue microenvironment. To meet this great challenge, we developed the Hyperion™ Imaging System.
“The impact of this first-in-class technology stands to be especially profound in oncology, immunology and immunotherapy research. With more than 30 systems enabled globally, progress in applying this innovative technology to ask new questions across a number of disease research areas is truly impressive .”
—Chris Linthwaite, President and CEO, Fluidigm
The Hyperion Imaging System brings imaging capability together with proven CyTOF® technology to set a new standard in highly multiplexed protein detection. Surpassing the inherent limitations of fluorescence detection, this system enables researchers to simultaneously image 4 to 37 protein markers in tissues and tumors by Imaging Mass Cytometry™. Ideal for deep profiling of precious formalin-fixed, paraffin-embedded (FFPE) and fresh frozen tissue samples, the Hyperion Imaging System empowers researchers to uncover new biomarker correlations and cellular social networks in the context of the tissue microenvironment—all from a single slide.
As with any new research application, having access to optimized reagents, analytical tools and training is essential for success. We designed the Hyperion Imaging System workflow with this in mind. It is accompanied by a pathologist-verified Maxpar® imaging antibody portfolio, antibody labeling kits, a software suite for image acquisition and data analysis, and experienced Fluidigm service and support. With the ability to utilize up to 135 channels to detect additional parameters, the system is well-suited to meet researchers needs today and well into the future.
A step jump of this magnitude doesn’t happen every day in life sciences. The impact of this first-in-class technology stands to be especially profound in oncology, immunology and immunotherapy research. With more than 30 systems enabled globally, truly impressive progress is being made in applying this innovative technology to ask new questions across a number of disease research areas.
I invite you to join with us and the growing scientific community in powering this revolution in tissue imaging to create breakthroughs today that will enable the development of better diagnostics and more effective therapies for tomorrow.
Sign up to recieve more information about Imaging Mass Cytometry.
For Research Use Only. Not for use in diagnostic procedures.